Preguntas de entrevista investigadas, descripción del proceso y señales de dificultad en Eli Lilly, compiladas por el equipo de investigación de Primly.
6 experienciasDificultad 3.7/5Pharma
Regulatory Affairs Manager
virtual
· Dificultad 4/5
Candidates report starting with a recruiter screen covering regulatory scope (US, EU, global), therapeutic-area fit, and experience leading cross-functional submission workstreams. A second stage is typically a hiring manager interview focused on strategy, risk tradeoffs, and how the candidate influences clinical, safety, CMC, and labeling partners without direct authority. Many processes then move to a multi-interviewer virtual panel that includes regulatory leadership and key matrix partners, where interviewers test scenario-based thinking around variations, lifecycle management, and health authority interactions. Some candidates describe a short presentation or discussion prompt, for example outlining a regulatory strategy for a labeling update, a post-approval commitment, or an expedited pathway scenario, with follow-up questions probing clarity and decision logic. Final steps often include broader leadership and culture interviews emphasizing judgment, accountability, and communication in high-stakes, time-sensitive settings, followed by references and standard background checks.
Given a product with emerging safety signals in post-market data, how would you assess whether the issue triggers a labeling change, a Dear HCP communication, or additional studies, and how would you engage internal governance?
Describe a time you led a cross-functional regulatory submission or major variation. What were the toughest points of alignment across clinical, safety, and CMC, and how did you resolve them?
How do you structure a global regulatory strategy to balance speed to market with long-term lifecycle flexibility, particularly around indications, dosing, and post-approval commitments?
A health authority asks for additional analyses that will delay a target action date. How do you triage the request, negotiate scope, and communicate the impact internally?
What does ‘integrity’ look like in regulatory decision-making when internal stakeholders strongly prefer an aggressive position? Provide an example of how you would respond.
Clinical Research Associate (CRA)
virtual
· Dificultad 3/5
Candidates report an initial recruiter screen focused on location flexibility, travel expectations, therapeutic-area interest, and baseline knowledge of GCP and clinical trial workflows. The next step is typically a hiring manager interview with a clinical operations leader that probes monitoring fundamentals, documentation habits, and comfort handling site relationships. Many processes then include a panel-style virtual interview with cross-functional partners such as clinical trial managers, data management, or quality, designed to test collaboration and escalation judgment. Some candidates also describe a brief written or case-style exercise, for example summarizing how to respond to a protocol deviation, missed visit window, or informed-consent issue. Final steps often include a values and culture conversation aligned to Lilly’s emphasis on integrity, patient focus, and speaking up, followed by reference checks and compliance-related onboarding steps once an offer is extended.
Walk through how a monitoring visit is planned and executed, including what source data you prioritize and how you document follow-up items in the visit report.
A site reports they re-consented a patient after a procedure occurred because the latest ICF version was not used. What do you do in the moment, what do you document, and what do you escalate?
Describe a time you had to deliver difficult feedback to a stakeholder about compliance or quality. How did you handle pushback?
How do you decide when an issue is a protocol deviation versus an exception you can resolve at the site level, and when to escalate to the study team?
Lilly teams emphasize integrity and patient safety. Tell an example of when you raised a concern or stopped a process because something did not feel right.
Software Engineer
virtual
· Dificultad 3/5
Recruiter screen, coding phone, virtual onsite with coding, system design, deep-dive, and behavioral.
Tell me about owning a feature with patient-app implications.
Describe debugging a hard issue.
Walk me through how you'd design a connected-insulin-pen ecosystem.
How do you partner with clinical teams on a feature?